Literature DB >> 2706443

Cytoskeletal abnormalities in motor neuron disease. An immunocytochemical study.

P N Leigh1, A Dodson, M Swash, J P Brion, B H Anderton.   

Abstract

Immunocytochemistry with antibodies against cytoskeletal proteins has been used to search for molecular differences in the spinal cord from patients with motor neuron disease (MND) of amyotrophic lateral sclerosis type and normal spinal cord. Monoclonal antibodies which recognize phosphorylated neurofilament epitopes diffusely labelled a proportion of normal and MND anterior horn cells, but did not permit differentiation between normal and MND tissue. However, in some MND and control anterior horn cells, dense 'floccular' accumulations were labelled by antibodies recognizing phosphorylated neurofilament epitopes. These accumulations of phosphorylated neurofilaments suggest abnormalities of cytoskeletal regulation, but were neither a common nor a specific feature of MND. Axonal spheroids, which were as common in normal as in MND tissue, were labelled by all antineurofilament antibodies. Normal-appearing axons, but not spheroids, in MND and control tissue were identified by an antiactin antibody, indicating that actin may be absent from the cytoplasmic domain which gives rise to spheroids. In summary, we have not found specific posttranslational changes of cytoskeletal proteins in MND and, in particular, phosphorylated neurofilament epitopes are common to both MND and control anterior horn cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2706443     DOI: 10.1093/brain/112.2.521

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  24 in total

Review 1.  Motor neuron disease.

Authors:  M Swash
Journal:  Postgrad Med J       Date:  1992-07       Impact factor: 2.401

2.  alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases.

Authors:  Nigel J Cairns; Kunihiro Uryu; Eileen H Bigio; Ian R A Mackenzie; Marla Gearing; Charles Duyckaerts; Hideaki Yokoo; Yoichi Nakazato; Evelyn Jaros; Robert H Perry; Steven E Arnold; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2004-05-28       Impact factor: 17.088

3.  Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells.

Authors:  G Sobue; Y Hashizume; T Yasuda; E Mukai; T Kumagai; T Mitsuma; J Q Trojanowski
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

4.  Phosphorylated high molecular weight neurofilament protein in the peripheral motor, sensory and sympathetic neuronal perikarya: system-dependent normal variations and changes in amyotrophic lateral sclerosis and multiple system atrophy.

Authors:  T Itoh; G Sobue; E Ken; T Mitsuma; A Takahashi; J Q Trojanowski
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 5.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

6.  Neuropathological changes in ten cases of neuronal intermediate filament inclusion disease (NIFID): a study using alpha-internexin immunohistochemistry and principal components analysis (PCA).

Authors:  R A Armstrong; E Kerty; K Skullerud; N J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

7.  Ubiquitin-immunoreactive filamentous inclusions in anterior horn cells of Guamanian and non-Guamanian amyotrophic lateral sclerosis.

Authors:  S Matsumoto; A Hirano; S Goto
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

8.  Reversibility of neurofilamentous inclusion formation following repeated sublethal intracisternal inoculums of AlCl3 in New Zealand white rabbits.

Authors:  M J Strong; S Gaytan-Garcia; D M Jakowec
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Neurofilament and glial alterations in the cerebral cortex in amyotrophic lateral sclerosis.

Authors:  D Troost; P A Sillevis Smitt; J M de Jong; D F Swaab
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 10.  Amyotrophic lateral sclerosis.

Authors:  Lokesh C Wijesekera; P Nigel Leigh
Journal:  Orphanet J Rare Dis       Date:  2009-02-03       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.